Authors: WEHNERT A VANDERBURGHT M SLOTHNIELSEN M

Citation: A. Wehnert et al., COMPARING SERTINDOLE CLINICAL-DATA AND PATIENTS ACROSS THE OCEANS, Schizophrenia research, 24(1-2), 1997, pp. 203-203

Authors: KARLE J CLEMMESEN L HANSEN L ANDERSEN M ANDERSEN J FENSBO C SLOTHNIELSEN M SKRUMSAGER BK LUBLIN H GERLACH J

Citation: J. Karle et al., NNC-01-0687, A SELECTIVE DOPAMINE D1 RECEPTOR ANTAGONIST, IN THE TREATMENT OF SCHIZOPHRENIA, Psychopharmacology, 121(3), 1995, pp. 328-329

Authors: KARLSSON P FARDE L HALLDIN C SEDVALL G YNDDAL L SLOTHNIELSEN M

Citation: P. Karlsson et al., ORAL-ADMINISTRATION OF NNC-756 - A PLACEBO-CONTROLLED PET STUDY OF D-1-DOPAMINE RECEPTOR OCCUPANCY AND PHARMACODYNAMICS IN MAN, Psychopharmacology, 119(1), 1995, pp. 1-8

Authors: HOYBERG OJ FENSBO C REMVIG J LINGJAERDE O SLOTHNIELSEN M SALVESEN I

Citation: Oj. Hoyberg et al., RISPERIDONE VERSUS PERPHENAZINE IN THE TREATMENT OF CHRONIC-SCHIZOPHRENIC PATIENTS WITH ACUTE EXACERBATIONS, Acta psychiatrica Scandinavica, 88(6), 1993, pp. 395-402